Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	molecular adaptor activity	TRERF1 COL4A2 SUPT20HL1 NCOR2 MYBBP1A ABI2 ZMIZ2 BBS4 SUPT20HL2 TRIM21 LTBP1 MAML2 MED13L AHDC1 MED13 NUP153 DCAF12	1.25e-05	1356	77	17	GO:0060090
GeneOntologyMolecularFunction	transcription coregulator activity	TRERF1 SUPT20HL1 NCOR2 MYBBP1A ZMIZ2 SUPT20HL2 TRIM21 MAML2 MED13L MED13	5.81e-05	562	77	10	GO:0003712
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	TRERF1 SUPT20HL1 NCOR2 MYBBP1A ABI2 ZMIZ2 BBS4 SUPT20HL2 TRIM21 MAML2 MED13L MED13 NUP153 DCAF12	1.24e-04	1160	77	14	GO:0030674
GeneOntologyMolecularFunction	chromatin binding	TRIM66 NCOR2 PYGO2 ASXL3 ESR1 AUTS2 CHD8 TASOR AHDC1 NUP153	5.30e-04	739	77	10	GO:0003682
GeneOntologyCellularComponent	centriole	DZIP1L CEP83 CEP41 BBS4 WDR90 TSKS	4.47e-05	172	78	6	GO:0005814
Domain	Med13_N	MED13L MED13	1.68e-05	2	77	2	PF11597
Domain	Mediator_Med13_N_met/fun	MED13L MED13	1.68e-05	2	77	2	IPR021643
Domain	Mediator_Med13	MED13L MED13	1.68e-05	2	77	2	IPR009401
Domain	Med13_C	MED13L MED13	1.68e-05	2	77	2	PF06333
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	TRERF1 ATXN2L NCOR2 RBM12 PRRC2C ZMIZ2 CKAP5 CHD8 MED13L RPA2 AHDC1 VARS1 ZYX NUP153	1.75e-07	1103	79	14	34189442
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TRERF1 NCOR2 MYBBP1A ITCH DST CAMKV ABI2 LZTS1 PRRC2C CKAP5 CHD8 TRIM21 NUP153	2.53e-07	963	79	13	28671696
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	RBM12 DST MAST4 HPS4 AUTS2 CHD8 WDR90 MAML2 ANKLE2 MED13	3.43e-07	529	79	10	14621295
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	TRERF1 PLEKHG4B NCOR2 ESR1 ZMIZ2 TNK2 WDR90 MAML2 NUP153	5.95e-07	430	79	9	35044719
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	DACT1 NCOR2 SETD1B DST ZFP36L2 ZMIZ2 MEX3D TNK2 CHD8 WDR90 MED13L AHDC1 MED13	1.19e-06	1105	79	13	35748872
Pubmed	Interaction network of human early embryonic transcription factors.	TRERF1 NCOR2 PYGO2 ASXL3 ZMIZ2 AUTS2 CHD8 AHDC1	1.39e-06	351	79	8	38297188
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	TRERF1 RBM12 PYGO2 CHD8 MED13L AHDC1 MED13	2.69e-06	268	79	7	33640491
Pubmed	Estrogen receptor α regulates tripartite motif-containing protein 21 expression, contributing to dysregulated cytokine production in systemic lupus erythematosus.	ESR1 TRIM21	5.09e-06	2	79	2	24449583
Pubmed	Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen.	NCOR2 ESR1	5.09e-06	2	79	2	9171229
Pubmed	E2/Estrogen receptor/sjogren syndrome-associated autoantigen relieves coactivator activator-induced G1/S arrest to promote breast tumorigenicity.	ESR1 TRIM21	5.09e-06	2	79	2	24567374
Pubmed	Mediator complex component MED13 regulates zygotic genome activation and is required for postimplantation development in the mouse.	MED13L MED13	5.09e-06	2	79	2	29325037
Pubmed	The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity.	NCOR2 ESR1	5.09e-06	2	79	2	17591692
Pubmed	Tetratricopeptide repeat domain 9A negatively regulates estrogen receptor alpha activity.	ESR1 TTC9	5.09e-06	2	79	2	25798063
Pubmed	The SMRT coregulator enhances growth of estrogen receptor-α-positive breast cancer cells by promotion of cell cycle progression and inhibition of apoptosis.	NCOR2 ESR1	5.09e-06	2	79	2	24971610
Pubmed	The local microenvironment instigates the regulation of mammary tetratricopeptide repeat domain 9A during lactation and involution through local regulation of the activity of estrogen receptor α.	ESR1 TTC9	5.09e-06	2	79	2	22917536
Pubmed	Corepressor subnuclear organization is regulated by estrogen receptor via a mechanism that requires the DNA-binding domain.	NCOR2 ESR1	5.09e-06	2	79	2	15713534
Pubmed	[Expression of ER alpha and SMRT in apoptosis of breast cancer cells induced by tamoxifen].	NCOR2 ESR1	5.09e-06	2	79	2	18546531
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	RBM12 DST CKAP5 TASOR MED13	1.22e-05	130	79	5	12421765
Pubmed	Defining the membrane proteome of NK cells.	MPP1 ATXN2L NCOR2 MYBBP1A ITCH PRRC2C ICAM1 CEP41 CKAP5 TNK2 ANKLE2 MED13	1.25e-05	1168	79	12	19946888
Pubmed	Prediction of the coding sequences of unidentified human genes. XXI. The complete sequences of 60 new cDNA clones from brain which code for large proteins.	PLEKHG4B ZMIZ2 WDR90 DCAF12	1.33e-05	63	79	4	11572484
Pubmed	A human MAP kinase interactome.	DST NDEL1 HPS4 TNK2 CHD8 TRIM21 ZYX NUP153	1.50e-05	486	79	8	20936779
Pubmed	Functional Variants in Notch Pathway Genes NCOR2, NCSTN, and MAML2 Predict Survival of Patients with Cutaneous Melanoma.	NCOR2 MAML2	1.53e-05	3	79	2	25953768
Pubmed	Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT.	NCOR2 ESR1	1.53e-05	3	79	2	15802375
Pubmed	Coassociation of estrogen receptor and p160 proteins predicts resistance to endocrine treatment; SRC-1 is an independent predictor of breast cancer recurrence.	MYBBP1A ESR1	1.53e-05	3	79	2	19276281
Pubmed	The p38-interacting protein (p38IP) regulates G2/M progression by promoting α-tubulin acetylation via inhibiting ubiquitination-induced degradation of the acetyltransferase GCN5.	SUPT20HL1 SUPT20HL2	1.53e-05	3	79	2	24220028
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ATXN2L ITCH DST MAST4 MAP2 ZFP36L2 PRRC2C CKAP5 ZYX ARAP2	2.53e-05	861	79	10	36931259
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	ATXN2L NCOR2 RBM12 ZMIZ2 AUTS2	2.59e-05	152	79	5	38360978
Pubmed	Relationship between estrogen receptor-alpha polymorphism and serum levels of vascular cell adhesion molecule-1, intercellular adhesion molecule-1, C-reactive protein and homocysteine in postmenopausal women.	ESR1 ICAM1	3.05e-05	4	79	2	17891599
Pubmed	FBXL19 recruits CDK-Mediator to CpG islands of developmental genes priming them for activation during lineage commitment.	MED13L MED13	3.05e-05	4	79	2	29809150
Pubmed	ACK1/TNK2 tyrosine kinase: molecular signaling and evolving role in cancers.	ESR1 TNK2	3.05e-05	4	79	2	25347744
Pubmed	A CRISPR-based screen for Hedgehog signaling provides insights into ciliary function and ciliopathies.	DST ABCA13 DZIP1L CHD8 LTBP1 ZYX	4.74e-05	284	79	6	29459677
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	TRERF1 NCOR2 DST ZMIZ2 CKAP5 CHD8 TASOR	4.74e-05	418	79	7	34709266
Pubmed	ERbeta Binds N-CoR in the Presence of Estrogens via an LXXLL-like Motif in the N-CoR C-terminus.	NCOR2 ESR1	5.07e-05	5	79	2	12904255
Pubmed	Combinatorial roles of the nuclear receptor corepressor in transcription and development.	NCOR2 MAP2	5.07e-05	5	79	2	11030619
Pubmed	CUE domain containing 2 regulates degradation of progesterone receptor by ubiquitin-proteasome.	NCOR2 ESR1	5.07e-05	5	79	2	17347654
Pubmed	Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer.	NCOR2 ESR1	5.07e-05	5	79	2	14715875
Pubmed	Cooperative activation of cyclin D1 and progesterone receptor gene expression by the SRC-3 coactivator and SMRT corepressor.	NCOR2 ESR1	5.07e-05	5	79	2	20392877
Pubmed	A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition.	SETD1B ZFP36L2 ASXL3 AUTS2 DGKG MED13L NUP153	5.75e-05	431	79	7	33660365
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	ATXN2L MYBBP1A GTF2H3 SETD1B CHD8 RPA2 NUP153	6.55e-05	440	79	7	34244565
Pubmed	DNA Damage Regulates Translation through β-TRCP Targeting of CReP.	DACT1 MED13L MED13	7.01e-05	35	79	3	26091241
Pubmed	MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer.	NCOR2 ESR1	7.60e-05	6	79	2	20388878
Pubmed	Conditional knockout of tumor overexpressed gene in mouse neurons affects RNA granule assembly, granule translation, LTP and short term habituation.	MAP2 CKAP5	7.60e-05	6	79	2	23936366
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	NCOR2 RBM12 PYGO2 PRRC2C AUTS2 AHDC1 NUP153	8.29e-05	457	79	7	32344865
Pubmed	Human transcription factor protein interaction networks.	TRERF1 NCOR2 MYBBP1A RBM12 DST PYGO2 PRRC2C ESR1 ZMIZ2 AUTS2 CHD8 RPA2	8.86e-05	1429	79	12	35140242
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	ATXN2L MAP9 MYBBP1A DST NDEL1 OXR1 MAP2 CAMKV LZTS1 PRRC2C CKAP5 VARS1	8.98e-05	1431	79	12	37142655
Pubmed	Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.	ATXN2L MYBBP1A GTF2H3 CKAP5 TRIM21 RPA2 VARS1 ZYX NUP153	9.18e-05	809	79	9	32129710
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	COL4A2 DACT1 NCOR2 HOXB3 PYGO2 ABI2 TNK2 CHD8 C1orf94 AHDC1 MED13	9.28e-05	1215	79	11	15146197
Pubmed	Prediction of the coding sequences of unidentified human genes. XIV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	SETD1B PRRC2C MED13L TASOR	9.54e-05	104	79	4	10470851
Pubmed	Complete loss of Ndel1 results in neuronal migration defects and early embryonic lethality.	NDEL1 MAP2	1.06e-04	7	79	2	16107726
Pubmed	The TRAP100 component of the TRAP/Mediator complex is essential in broad transcriptional events and development.	MED13L MED13	1.06e-04	7	79	2	12093747
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	DST PRRC2C CKAP5 CHD8 ANKLE2 AHDC1	1.12e-04	332	79	6	37433992
Pubmed	Large-scale phosphomimetic screening identifies phospho-modulated motif-based protein interactions.	TRERF1 NCOR2 ITCH MAP2	1.19e-04	110	79	4	37219487
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	GTF2H3 DST ZFP36L2 ABI2 ESR1 CEP83 CKAP5 CHD8 TASOR AHDC1 VARS1 MED13	1.37e-04	1497	79	12	31527615
Pubmed	Proteome analysis of the HIV-1 Gag interactome.	ATXN2L MYBBP1A PRRC2C	1.40e-04	44	79	3	25010285
Pubmed	Replication of previous genome-wide association studies of bone mineral density in premenopausal American women.	ESR1 CKAP5 DGKG	1.40e-04	44	79	3	20200978
Pubmed	Crosstalk between Nodal/activin and MAPK p38 signaling is essential for anterior-posterior axis specification.	SUPT20HL1 SUPT20HL2	1.41e-04	8	79	2	21802298
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	ATXN2L MYBBP1A PYGO2 CHD8 ANKLE2 ZYX NUP153	1.50e-04	503	79	7	16964243
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	TRIM66 ITCH DST OXR1 HPS4 CKAP5 GPR37L1 RNF216 MED13L VARS1 MED13	1.52e-04	1285	79	11	35914814
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	RBM12 DST AUTS2 CHD8 MED13L	1.66e-04	225	79	5	12168954
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	ABCA13 PRRC2C ASXL3 CKAP5 C1orf94 NUP153	1.76e-04	361	79	6	26167880
Pubmed	SAP30, a component of the mSin3 corepressor complex involved in N-CoR-mediated repression by specific transcription factors.	NCOR2 ESR1	1.82e-04	9	79	2	9702189
Pubmed	Mena, a relative of VASP and Drosophila Enabled, is implicated in the control of microfilament dynamics.	TNK2 ZYX	1.82e-04	9	79	2	8861907
Pubmed	Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins.	ITCH ICAM1	1.82e-04	9	79	2	14973438
Pubmed	Ltbp1L is focally induced in embryonic mammary mesenchyme, demarcates the ductal luminal lineage and is upregulated during involution.	ESR1 LTBP1	1.82e-04	9	79	2	24262428
Pubmed	An improved smaller biotin ligase for BioID proximity labeling.	DST ZFP36L2 PRRC2C NUP153	1.82e-04	123	79	4	26912792
Pubmed	Full activation of estrogen receptor alpha activation function-1 induces proliferation of breast cancer cells.	NCOR2 ESR1	2.27e-04	10	79	2	12738788
Pubmed	Enhancer activation requires trans-recruitment of a mega transcription factor complex.	NCOR2 ESR1	2.27e-04	10	79	2	25303530
Pubmed	HIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxia.	MED13L MED13	2.27e-04	10	79	2	23746844
Pubmed	Phosphoproteomic analysis of the developing mouse brain.	ENAM MYBBP1A MAP2 CAMKV CEP41	2.50e-04	246	79	5	15345747
Pubmed	Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.	ATXN2L MYBBP1A PRRC2C CKAP5 TRIM21 TASOR ZYX	2.61e-04	551	79	7	34728620
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ATXN2L MYBBP1A RBM12 DST PRRC2C CKAP5 TASOR ZYX NUP153	2.68e-04	934	79	9	33916271
Pubmed	Glucagon regulates gluconeogenesis through KAT2B- and WDR5-mediated epigenetic effects.	SUPT20HL1 SUPT20HL2	2.76e-04	11	79	2	24051374
Pubmed	Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.	ATXN2L NCOR2 RBM12 PRRC2C RPA2 ZYX	3.01e-04	399	79	6	35987950
Pubmed	Reproducible genetic associations between candidate genes and clinical knee osteoarthritis in men and women.	NCOR2 ESR1	3.31e-04	12	79	2	16453284
Pubmed	Inhibition of RIF1 by SCAI Allows BRCA1-Mediated Repair.	AHDC1 NUP153	3.31e-04	12	79	2	28700933
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TRERF1 ATXN2L NCOR2 MYBBP1A CKAP5 ZYX MED13 NUP153	3.77e-04	774	79	8	15302935
Pubmed	TIF1delta, a novel HP1-interacting member of the transcriptional intermediary factor 1 (TIF1) family expressed by elongating spermatids.	TRIM66 ESR1	3.91e-04	13	79	2	15322135
Pubmed	MED12 Regulates HSC-Specific Enhancers Independently of Mediator Kinase Activity to Control Hematopoiesis.	MED13L MED13	3.91e-04	13	79	2	27570068
Pubmed	Differential gene expression in migrating cortical interneurons during mouse forebrain development.	DACT1 DGKG	3.91e-04	13	79	2	20151419
Pubmed	Functional proteomics mapping of a human signaling pathway.	COL4A2 NCOR2 DST MAST4 RNF216 ANKLE2 ZYX	3.98e-04	591	79	7	15231748
Pubmed	Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia.	NCOR2 DST NDEL1 ABI2	3.98e-04	151	79	4	17043677
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	MAP9 MYBBP1A PDE6A DST PRRC2C DZIP1L CEP83 ANKLE2 TASOR VARS1 MED13	4.07e-04	1442	79	11	35575683
Pubmed	A cytoplasmic role of Wnt/β-catenin transcriptional cofactors Bcl9, Bcl9l, and Pygopus in tooth enamel formation.	ENAM PYGO2	4.55e-04	14	79	2	28174279
Pubmed	New sequence variants associated with bone mineral density.	ESR1 CKAP5	4.55e-04	14	79	2	19079262
Pubmed	Selection system for genes encoding nuclear-targeted proteins.	RBM12 ZMIZ2	4.55e-04	14	79	2	9853615
Pubmed	Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication.	TRIM66 SETD1B RNF216 ZYX NUP153	4.75e-04	283	79	5	18854154
Pubmed	FBXO45-MYCBP2 regulates mitotic cell fate by targeting FBXW7 for degradation.	MED13L MED13	5.25e-04	15	79	2	31285543
Pubmed	Setd1b, encoding a histone 3 lysine 4 methyltransferase, is a maternal effect gene required for the oogenic gene expression program.	SETD1B ESR1	5.25e-04	15	79	2	28619824
Pubmed	C2cd3 is critical for centriolar distal appendage assembly and ciliary vesicle docking in mammals.	CEP83 BBS4	5.25e-04	15	79	2	24469809
Pubmed	Pygo2 expands mammary progenitor cells by facilitating histone H3 K4 methylation.	PYGO2 ESR1	5.99e-04	16	79	2	19487454
Pubmed	Mastermind-like 1 (MamL1) and mastermind-like 3 (MamL3) are essential for Notch signaling in vivo.	MAP2 MAML2	5.99e-04	16	79	2	22069191
Pubmed	Excitatory neuronal CHD8 in the regulation of neocortical development and sensory-motor behaviors.	MAP2 CHD8	5.99e-04	16	79	2	33626347
Pubmed	A protein interaction landscape of breast cancer.	MYBBP1A DST ESR1 ICAM1 LTBP1 RPA2 NUP153	6.03e-04	634	79	7	34591612
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	DST CKAP5 LTBP1 WDR90 MED13L ZYX MED13	6.68e-04	645	79	7	25281560
Pubmed	LINC00240 in the 6p22.1 risk locus promotes gastric cancer progression through USP10-mediated DDX21 stabilization.	PRRC2C CKAP5	6.78e-04	17	79	2	37072811
Pubmed	Genome-wide association analysis of genetic generalized epilepsies implicates susceptibility loci at 1q43, 2p16.1, 2q22.3 and 17q21.32.	MAST4 C1orf94	6.78e-04	17	79	2	22949513
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	MYBBP1A PRRC2C CHD8 TRIM21 TASOR AHDC1	7.05e-04	469	79	6	27634302
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	ATXN2L MYBBP1A DST PRRC2C CKAP5 CHD8 NUP153	7.18e-04	653	79	7	22586326
Pubmed	SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.	TRERF1 ATXN2L NCOR2 MYBBP1A PRRC2C ZYX NUP153	7.30e-04	655	79	7	35819319
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	ATXN2L NCOR2 MYBBP1A SETD1B PRRC2C CHD8	7.54e-04	475	79	6	31040226
Interaction	TLE3 interactions	TRERF1 NCOR2 RBM12 PYGO2 ESR1 ZMIZ2 AUTS2 RNF216 RPA2 AHDC1	1.64e-06	376	77	10	int:TLE3
Interaction	CEP83 interactions	LZTS1 ESR1 CEP83 CKAP5	1.46e-05	39	77	4	int:CEP83
Interaction	CEBPA interactions	TRERF1 ATXN2L NCOR2 ITCH RBM12 PRRC2C ESR1 ZMIZ2 CKAP5 CHD8 MED13L RPA2 AHDC1 VARS1 ZYX NUP153	1.56e-05	1245	77	16	int:CEBPA
Interaction	AR interactions	TRERF1 NCOR2 MYBBP1A GTF2H3 RBM12 PYGO2 ESR1 ZMIZ2 SHC4 TNK2 CHD8 MED13L AHDC1 MED13	2.07e-05	992	77	14	int:AR
Interaction	MAPRE1 interactions	MAP9 DST NDEL1 MAST4 MAP2 PRRC2C CKAP5 WDR90 RPA2 NUP153	2.53e-05	514	77	10	int:MAPRE1
Cytoband	Xp22.11	SUPT20HL1 SUPT20HL2	6.01e-04	21	79	2	Xp22.11
Cytoband	Ensembl 112 genes in cytogenetic band chr12q24	NCOR2 GTF2H3 SETD1B MED13L ANKLE2	7.67e-04	415	79	5	chr12q24
Cytoband	7q32	CEP41 ZYX	7.87e-04	24	79	2	7q32
Cytoband	Ensembl 112 genes in cytogenetic band chr1p35	RPA2 C1orf94 AHDC1	1.74e-03	137	79	3	chr1p35
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	NCOR2 ITCH DST ZFP36L2 PRRC2C CKAP5 MED13L ANKLE2 TASOR AHDC1 MED13 NUP153 ARAP2	1.58e-06	856	79	13	M4500
Coexpression	DOANE_RESPONSE_TO_ANDROGEN_DN	MPP1 DST MAST4 ZFP36L2 PRRC2C LTBP1 MED13L	8.64e-06	242	79	7	M12816
Coexpression	GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP	SETD1B NDEL1 PRRC2C HPS4 MAML2 NUP153	2.86e-05	196	79	6	M4928
Coexpression	GSE37301_LYMPHOID_PRIMED_MPP_VS_GRAN_MONO_PROGENITOR_UP	MPP1 ATXN2L RBM12 NDEL1 ICAM1 DGKG	3.20e-05	200	79	6	M8860
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	TRERF1 ATXN2L RBM12 ZFP36L2 ANKRD10 AUTS2 RNF216 TNK2 ANKLE2 RPA2 TASOR ZYX MED13 NUP153 ARAP2	3.41e-05	1492	79	15	M40023
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	DST MAST4 AUTS2 TTC9 MED13L AHDC1 NUP153	3.44e-05	300	79	7	M8702
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000	ITCH NDEL1 MAST4 PRRC2C ESR1 CHD8 NUP153	1.03e-05	210	76	7	gudmap_developingGonad_e18.5_ovary_1000_k2
CoexpressionAtlas	DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000	ITCH NDEL1 MAST4 PRRC2C ESR1 CHD8	1.70e-05	151	76	6	gudmap_developingGonad_P2_ovary_1000_k5
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_100	NDEL1 MAST4 CHD8	1.94e-05	15	76	3	gudmap_developingGonad_e18.5_epididymis_100_k4
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_200	ITCH NDEL1 MAST4 PRRC2C ESR1 CHD8	2.90e-05	166	76	6	gudmap_developingGonad_e16.5_epididymis_200
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#4_top-relative-expression-ranked_200	NDEL1 MAST4 CHD8	3.46e-05	18	76	3	gudmap_developingGonad_P2_epididymis_200_k4
CoexpressionAtlas	dev gonad_e12.5_F_DevVasOvary_Flk_k-means-cluster#2_top-relative-expression-ranked_1000	SCARF1 MPP1 RASIP1 NDEL1 ICAM1 TTC9	5.00e-05	183	76	6	gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_k2_1000
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_100	NDEL1 ESR1 CHD8	6.46e-05	22	76	3	gudmap_developingGonad_e16.5_epididymis_100_k3
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_200	NDEL1 MAST4 CHD8	7.41e-05	23	76	3	gudmap_developingGonad_e18.5_epididymis_200_k2
CoexpressionAtlas	DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#2_top-relative-expression-ranked_500	NDEL1 MAST4 ESR1 CHD8	8.69e-05	65	76	4	gudmap_developingGonad_P2_ovary_500_k2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000	DST OXR1 MAP2 SUSD5 ASXL3 ESR1 AUTS2 LTBP1 HIF3A MED13L MED13	8.76e-05	769	76	11	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500	ITCH NDEL1 MAST4 PRRC2C ASXL3 ESR1 CHD8 HIF3A	1.01e-04	406	76	8	gudmap_developingGonad_e16.5_epididymis_500
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_200	NDEL1 ESR1 CHD8	1.08e-04	26	76	3	gudmap_developingGonad_e18.5_ovary_200_k3
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#2_top-relative-expression-ranked_500	ITCH NDEL1 MAST4 PRRC2C ESR1	1.28e-04	136	76	5	gudmap_developingGonad_P2_epididymis_500_k2
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000	ITCH NDEL1 MAST4 ESR1 CHD8 NUP153	1.56e-04	225	76	6	gudmap_developingGonad_e14.5_ ovary_1000_k3
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000	ITCH NDEL1 MAST4 PRRC2C ESR1 CHD8	1.76e-04	230	76	6	gudmap_developingGonad_e16.5_ovary_1000_k2
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500	ITCH NDEL1 MAST4 PRRC2C CHD8	2.03e-04	150	76	5	gudmap_developingGonad_e12.5_epididymis_k5_500
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_100	NDEL1 MAST4 ESR1 CHD8	2.25e-04	83	76	4	gudmap_developingGonad_e18.5_epididymis_100
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_100	ITCH NDEL1 ESR1 CHD8	2.35e-04	84	76	4	gudmap_developingGonad_e14.5_ epididymis_100
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_100	NDEL1 MAST4 ESR1 CHD8	2.58e-04	86	76	4	gudmap_developingGonad_e16.5_epididymis_100
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_200	ITCH NDEL1 MAST4 ESR1 CHD8	3.25e-04	166	76	5	gudmap_developingGonad_e18.5_epididymis_200
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_200	ITCH NDEL1 MAST4 ESR1 CHD8	3.34e-04	167	76	5	gudmap_developingGonad_e14.5_ epididymis_200
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_500	NDEL1 MAST4 ESR1 CHD8	4.08e-04	97	76	4	gudmap_developingGonad_e18.5_ovary_500_k3
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#1_top-relative-expression-ranked_500	ITCH NDEL1 MAST4 CHD8	4.76e-04	101	76	4	gudmap_developingGonad_e14.5_ ovary_500_k1
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000	ITCH NDEL1 MAST4 PRRC2C ANKRD10 HIF3A	5.12e-04	281	76	6	gudmap_developingGonad_e18.5_epididymis_1000_k3
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_500	ITCH NDEL1 ESR1 CHD8	6.34e-04	109	76	4	gudmap_developingGonad_e16.5_ovary_500_k5
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#1_top-relative-expression-ranked_100	ITCH NDEL1 ESR1	6.79e-04	48	76	3	gudmap_developingGonad_e14.5_ epididymis_100_k1
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500	ITCH NDEL1 MAST4 PRRC2C ASXL3 ESR1 CHD8	6.90e-04	413	76	7	gudmap_developingGonad_e14.5_ epididymis_500
ToppCell	Pericytes-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	COL4A2 DACT1 HOXB3 LZTS1 DGKG LTBP1	9.06e-07	183	79	6	4617b18da8d699a44e4c47980197b1e7eb951470
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 COL4A2 DST ESR1 LTBP1 HIF3A	1.16e-06	191	79	6	c54c420a94dc749ebc67fc64c5614663f4b9798d
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 COL4A2 DST ESR1 LTBP1 HIF3A	1.16e-06	191	79	6	806b94f567ea09a9f443cd4091e70cdb1253ac08
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 COL4A2 DST ESR1 LTBP1 HIF3A	1.16e-06	191	79	6	cb0aee740b08f7d5fdd2717ecf7429043b277ae7
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DST ZFP36L2 PRRC2C MAML2 TASOR	1.42e-05	173	79	5	869da6a65d1b9b7529c666ec44e3c8ddec2ea408
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DST ZFP36L2 PRRC2C MAML2 TASOR	1.42e-05	173	79	5	0672bd8a4a9d18af343d01f09253fb3388896c10
ToppCell	facs-Brain_Myeloid-Cerebellum-3m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DST ZFP36L2 PRRC2C MAML2 TASOR	1.42e-05	173	79	5	870e091ec30be01a900e1cb8b9ef1880e3b7b50d
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DST ZFP36L2 PRRC2C MAML2 TASOR	1.50e-05	175	79	5	1ea6cf9da26601646f57fa14d558a5e9e1f0b345
ToppCell	droplet-Heart-nan-3m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP2 SUSD5 DZIP1L DGKG TSKS	1.59e-05	177	79	5	dbdbdc8ed9ef0b529694242ef9f9f07a42e16005
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A2 MAP2 LZTS1 DGKG LTBP1	1.59e-05	177	79	5	a8625d14682183cf77cb51eaf11bc15a3528f586
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A2 MAP2 LZTS1 DGKG LTBP1	1.59e-05	177	79	5	3645e2f4a48283f290f85c49c3e79e3f58ac9aa6
ToppCell	droplet-Heart-nan-3m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP2 SUSD5 DZIP1L DGKG TSKS	1.63e-05	178	79	5	416f85e51f45ec7949451fd47611a84e33e87245
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A2 MAST4 MEX3D CEP83 TASOR	1.67e-05	179	79	5	025d414ec88d5680d99c8173e70ee3bb0b694f74
ToppCell	COVID-19-kidney-vSMC/Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	COL4A2 MAP2 LZTS1 DGKG LTBP1	1.67e-05	179	79	5	111b1084f73306bdeffaaf240e7dbb4f5bf33de1
ToppCell	human_hepatoblastoma-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	OXR1 ESR1 AUTS2 DGKG TTC9	1.67e-05	179	79	5	14fc8ccb6b215063d747643f47d780d2b237eb67
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D175\|Adult / Lineage, Cell type, age group and donor	TRERF1 COL4A2 RASIP1 HIF3A CCDC116	1.81e-05	182	79	5	8b4a07ebd7a133a33ef333cfa29d12c4f3d4d9ac
ToppCell	Basal\|World / shred by cell class for mouse tongue	DST ICAM1 ANKRD10 LTBP1 ZYX	1.86e-05	183	79	5	c6729a207526ff4aa48176207b9353176f631fea
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	DACT1 DST MAP2 LTBP1 HIF3A	1.96e-05	185	79	5	9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec
ToppCell	Control-Epithelial-Basal\|Epithelial / Disease state, Lineage and Cell class	DST ZFP36L2 ASXL3 PERM1 HIF3A	1.96e-05	185	79	5	d5d6d13e2f20b54ca55645b9a757b8599f4fd897
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	DACT1 DST MAP2 LTBP1 HIF3A	2.07e-05	187	79	5	13731298bc562ec29582f5da1b4c97261284f6f1
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL4A2 DST MAP2 ICAM1 ARAP2	2.07e-05	187	79	5	d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MAP2 LZTS1 SUSD5 DGKG LTBP1	2.17e-05	189	79	5	fac5c291a9a87418bb0878c3d624829bdbf1f428
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 COL4A2 ESR1 LTBP1 HIF3A	2.17e-05	189	79	5	c734e5693808a0333139e87bd5be2597a9252afe
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D231\|Adult / Lineage, Cell type, age group and donor	COL4A2 DST MAP2 ICAM1 ARAP2	2.17e-05	189	79	5	5a04cb25f8f0447b2cecdb6c3695029281aca26d
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 COL4A2 ESR1 LTBP1 HIF3A	2.23e-05	190	79	5	2e592323085ba9c019d678ac2a784462ab470ed9
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A2 MAP2 LZTS1 DGKG LTBP1	2.23e-05	190	79	5	5681c211baeed4af82a2bbc13420f6a7b487581c
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 COL4A2 ESR1 LTBP1 HIF3A	2.23e-05	190	79	5	445952b70abffadb6ccc1ed4bbf61a88b06b73b3
ToppCell	COVID-19-kidney-vSMC/Pericyte\|kidney / Disease (COVID-19 only), tissue and cell type	COL4A2 MAP2 LZTS1 DGKG LTBP1	2.29e-05	191	79	5	fad8eaa536001b911d05ae2b12150c2398cc6f88
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 MAP2 LZTS1 DGKG LTBP1	2.29e-05	191	79	5	7b0d42a877540dbb346a76a62403e0d5d3e07fa6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 MAP2 LZTS1 DGKG LTBP1	2.29e-05	191	79	5	cd854b9c426924fdc84bf7f411f6dea447143e79
ToppCell	renal_papilla_nuclei-Adult_normal_reference\|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	PLEKHG4B HOXB3 AUTS2 LTBP1 HIF3A	2.34e-05	192	79	5	6c106b91e46eabbe686a52a65a9c94ad9cbe9390
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	DST MAST4 MAML2 HIF3A ZYX	2.40e-05	193	79	5	9f69edc97b868d23998abc98928a2e89a885ef8a
ToppCell	IPF-Endothelial-VE_Arterial\|IPF / Disease state, Lineage and Cell class	RASIP1 MAST4 MAP2 LTBP1 HIF3A	2.40e-05	193	79	5	bf83b1fe9d38408f30eee4eb634341c04ef82791
ToppCell	Transplant_Alveoli_and_parenchyma-Mesenchymal-Smooth_muscle\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	COL4A2 MAP2 SUSD5 DGKG LTBP1	2.40e-05	193	79	5	9104b572d9c3c99080e4b7455993fbb944bf117d
ToppCell	nucseq-Mesenchymal-Myocytic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL4A2 HOXB3 LZTS1 DGKG LTBP1	2.46e-05	194	79	5	2d66091097e106c7bee22e5281f50724700bdf8d
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 COL4A2 DST ESR1 LTBP1	2.46e-05	194	79	5	90efdbd7f1c85fd7fd622b10340250b1d8fc1197
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 COL4A2 DST ESR1 LTBP1	2.46e-05	194	79	5	df82cce5ebeb73740b02cf816c6df82253cfd566
ToppCell	(3)_Chondrocytes-(30)_Chondro\|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis	COL4A2 DACT1 ICAM1 AUTS2 LTBP1	2.52e-05	195	79	5	f5597d3ed37770c6fa2b339f98a80ac7ecd4f9ff
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAP2 LZTS1 SUSD5 DGKG LTBP1	2.59e-05	196	79	5	b8759e6231e0254797d6c30930407b79440c57bb
ToppCell	background-Endothelial_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	COL4A2 RASIP1 MAST4 AUTS2 DGKG	2.59e-05	196	79	5	e6fb0bfab1779ec64a8c35d01519eaafbf62e977
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NCOR2 DST LZTS1 ANKRD10 AUTS2	2.59e-05	196	79	5	b8b9801181d7604871b48aebacb295d0a57a5eaf
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL4A2 LZTS1 SUSD5 DGKG LTBP1	2.59e-05	196	79	5	8c25fa61c117a60ddd4cbd2f95ae5b66f986a1ec
ToppCell	ASK440-Epithelial-Type_1\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	COL4A2 DST MAP2 ICAM1 ARAP2	2.65e-05	197	79	5	782449c522c9e16e72bf999a73090688a3aefe06
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL4A2 MAP2 SUSD5 DGKG LTBP1	2.65e-05	197	79	5	d16bb765afdc02406ffd7ce6a75bae72b66db66c
ToppCell	ASK428-Epithelial-Type_1\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	COL4A2 DST MAP2 ICAM1 ARAP2	2.65e-05	197	79	5	9ae6661c307791c3f0ecd3d378e3d917565e5498
ToppCell	356C-Epithelial_cells-Epithelial-I_(AT1)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PLEKHG4B COL4A2 DST MAP2 ICAM1	2.65e-05	197	79	5	69d5b8588046d119b5dff9a7fd6f49e97e00a5b7
ToppCell	356C-Epithelial_cells-Epithelial-I_(AT1)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PLEKHG4B COL4A2 DST MAP2 ICAM1	2.65e-05	197	79	5	e6cbfa267eb2e05b441fd034786faae07bb0e081
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SCARF1 COL4A2 RASIP1 ICAM1 HIF3A	2.72e-05	198	79	5	9ecf944984aade1bf902e3a92ea4d46a3696822f
ToppCell	Bronchus_Control_(B.)-Stromal-TX-Smooth_muscle-1\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	COL4A2 MAP2 LZTS1 SUSD5 DGKG	2.72e-05	198	79	5	0f1feed8a37293ae02465909f99548ab58dc7ce5
ToppCell	Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	COL4A2 MAP2 SUSD5 DGKG LTBP1	2.78e-05	199	79	5	8ff0fdcbe9661b013913731ec8b53d84836ca865
ToppCell	Biopsy_IPF-Mesenchymal-Smooth_Muscle_cells\|Biopsy_IPF / Sample group, Lineage and Cell type	COL4A2 LZTS1 SUSD5 DGKG LTBP1	2.78e-05	199	79	5	ffb871dc3d232a7bdc2d55d91b76e79883e8fa1b
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SCARF1 COL4A2 RASIP1 ICAM1 HIF3A	2.78e-05	199	79	5	ddfb725ccbcadbd188e20b60a7567e1f8245f18d
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL4A2 HOXB3 DST LTBP1 HIF3A	2.85e-05	200	79	5	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	COL4A2 LZTS1 SUSD5 DGKG LTBP1	2.85e-05	200	79	5	f599e4b051ac3dad11ad437e98dc8ea6754cca53
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Pericyte\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	COL4A2 DACT1 LZTS1 SUSD5 DGKG	2.85e-05	200	79	5	b22cae282591d8dead9869c2adbb9632615f50f7
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL4A2 RASIP1 DST MAST4 TNK2	2.85e-05	200	79	5	a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCell	LPS_only-Mesenchymal_myocytic-Pericyte\|LPS_only / Treatment groups by lineage, cell group, cell type	COL4A2 DACT1 LZTS1 SUSD5 DGKG	2.85e-05	200	79	5	8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f
ToppCell	primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Grm5\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ZFP36L2 SUSD5 GPR37L1 SHC4	1.10e-04	139	79	4	a957ea4e581646c76b16b6a7f89579b8c7ac35b6
ToppCell	PND01-03-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature_2\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	DACT1 LZTS1 ZMIZ2 PERM1	1.22e-04	143	79	4	abe6ec0f6956b87f394d537926eb2427fcfad93f
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYBBP1A CEP41 CDHR5 TTC9	1.22e-04	143	79	4	92ddc3e3f6ba78dd9daeb272c12503ec2650a874
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LZTS1 SUSD5 DGKG LTBP1	2.12e-04	165	79	4	9de841c1c95967c562720feba930246debc626fd
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LZTS1 SUSD5 DGKG LTBP1	2.12e-04	165	79	4	a612a7d3a5415ecacc3df8fbff0ce498f982aad0
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MAP2 LZTS1 DGKG LTBP1	2.12e-04	165	79	4	4f83ac71efc57be3668d8db1e62bad05dc6a5e2b
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LZTS1 SUSD5 DGKG LTBP1	2.12e-04	165	79	4	cdc94a640ec01c6892521bcd6f0ee0a66ff23866
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MAP2 LZTS1 DGKG LTBP1	2.12e-04	165	79	4	cd8de98af8a1a8a6c81d71fae807cc07f319f4c9
ToppCell	3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DST ABCA13 SHC4 LTBP1	2.32e-04	169	79	4	2456b3e7776e8a2214972be1b4d66a3ca5480ae0
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PLEKHG4B DST MAML2 ARAP2	2.32e-04	169	79	4	665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PLEKHG4B DST MAML2 ARAP2	2.32e-04	169	79	4	6614c9851537e4c21b1e45ff0cc3bad07ef9d034
ToppCell	Basal_cells-SSc-ILD_02\|World / lung cells shred on cell class, cell subclass, sample id	PLEKHG4B SHC4 PERM1 ARAP2	2.37e-04	170	79	4	776d4224a682b6c648041827efd69794f88906f0
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	COL4A2 DST MAP2 ICAM1	2.37e-04	170	79	4	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	P15\|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COL4A2 RASIP1 ICAM1 ARAP2	2.42e-04	171	79	4	155e7abd52b84d16146001f6ca49ca0c2294a823
ToppCell	Adult-Mesenchymal-pericyte_cell-D231\|Adult / Lineage, Cell type, age group and donor	COL4A2 RASIP1 LZTS1 DGKG	2.48e-04	172	79	4	858cee96c1c06160863b4adcd7023c0d678bd50f
ToppCell	facs-Kidney-nan-18m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DST MAP2 ABCA13 PERM1	2.48e-04	172	79	4	87a30a219b0a6979abb5fba292a2d8ea946fd849
ToppCell	facs-Kidney-nan-18m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DST MAP2 ABCA13 PERM1	2.48e-04	172	79	4	5030ac31709cac236bb58f4ef9d545d24690411a
ToppCell	Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL4A2 DGKG PERM1 LTBP1	2.53e-04	173	79	4	5416b092321c7d9b63f0418c60f2402a138355bf
ToppCell	Control-Epithelial_cells-AT1\|Control / group, cell type (main and fine annotations)	COL4A2 DST MAP2 ARAP2	2.59e-04	174	79	4	548d7f2b958a2bfd2c95eb049ceaab55a559c77d
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HOXB3 DST LTBP1 MAML2	2.65e-04	175	79	4	1799a7be623dc3bf53ba580a7c47d2619969d708
ToppCell	facs-Mammary_Gland-Mammary_Gland-3m-Endothelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SCARF1 RASIP1 SUSD5 GPR37L1	2.65e-04	175	79	4	c36b4526970db9ccfbe2c70b00961fab9f13b133
ToppCell	Pericytes-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	COL4A2 SUSD5 DGKG LTBP1	2.65e-04	175	79	4	ddf721023a7afc8085c5de17aa254a6575444c0f
ToppCell	facs-Mammary_Gland-Mammary_Gland-3m-Endothelial-endothelial_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SCARF1 RASIP1 SUSD5 GPR37L1	2.65e-04	175	79	4	c1e082538f31b5c98ac63f71dcca4a1211a14708
ToppCell	facs-Mammary_Gland-Mammary_Gland-3m-Endothelial-nan\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SCARF1 RASIP1 SUSD5 GPR37L1	2.65e-04	175	79	4	2f9b5bdf8a62e8e99d1c4f677a8e5525bfd3b4ce
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 COL4A2 MAP2 LTBP1	2.70e-04	176	79	4	9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 COL4A2 MAP2 LTBP1	2.70e-04	176	79	4	3f8274a7ab67f9f8a8923193763a5543cfe4defa
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAP2 LZTS1 DGKG LTBP1	2.76e-04	177	79	4	4943d040eee0f9dceaddc7498171281d170e271f
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAP2 LZTS1 DGKG LTBP1	2.76e-04	177	79	4	3f2272b577c862dba8ccfb41184054bbd0ace6f5
ToppCell	severe-Myeloid-Neutrophils_1\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	SCARF1 ZFP36L2 TTC9 MAML2	2.76e-04	177	79	4	d1ad35ee3d2a84b1d01126d0a38464ab858c00d0
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A2 OXR1 ABCA13 MAML2	2.76e-04	177	79	4	da8802a6351d3e510822f82e2fde8a4314a2216e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 LTBP1 RPA2 CCDC116	2.76e-04	177	79	4	b872ee91e01265b101b81bd304cf6b95d5419e68
ToppCell	wk_20-22-Hematologic_Lymphocytic-B-Late_pro-B\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	MPP1 PLEKHG4B ENAM HPS4	2.82e-04	178	79	4	4e28a8bd5a603518bfe993712ab785308691b5ff
ToppCell	10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages\|lymph-node_spleen / Manually curated celltypes from each tissue	SCARF1 MPP1 DST DZIP1L	2.95e-04	180	79	4	7be7d7a6906fff6dbdecd9cb013d855aba4eda2a
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A2 ESR1 AUTS2 LTBP1	2.95e-04	180	79	4	280ff5c8f292be1b88120db5ff1788b750644856
ToppCell	facs-Marrow-B-cells-3m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DACT1 GPR37L1 DISP3 TTC9	2.95e-04	180	79	4	c54af6fb11484dacd3efa1f10a487376ff820a5e
ToppCell	Bronchial_Biopsy-Mesenchymal-Smooth_muscle\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	LZTS1 SUSD5 DGKG LTBP1	2.95e-04	180	79	4	7085a851807e6a833965e1366946db0bbc5174e2
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A2 ESR1 AUTS2 LTBP1	2.95e-04	180	79	4	fdbd7c22044d9328a1e06e2f9a4451529d1df767
ToppCell	facs-Marrow-B-cells-3m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DACT1 GPR37L1 DISP3 TTC9	2.95e-04	180	79	4	07ac979b21be2425294d9818c48b5a1e6f014c19
ToppCell	RA-07._Pericyte\|RA / Chamber and Cluster_Paper	TRERF1 MAP2 LZTS1 MAML2	3.01e-04	181	79	4	8dfb42d096db6c2df9b41303a7199d134d4bff07
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A2 OXR1 ABCA13 MAML2	3.01e-04	181	79	4	071f9bb5d39070cdc473d9b0e094d196bc702b56
ToppCell	RA-07._Pericyte\|World / Chamber and Cluster_Paper	TRERF1 MAP2 LZTS1 MAML2	3.07e-04	182	79	4	2075efeae633550fb2eb026d0dfd741c8252482e
ToppCell	5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DST MAP2 CAMKV SHC4	3.07e-04	182	79	4	d6740bca2b974122b8451989365a94a81140afd1
ToppCell	droplet-Marrow-nan-3m-Hematologic-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZFP36L2 PRRC2C TASOR ARAP2	3.07e-04	182	79	4	e78ba2c5cae480c16a596ce7c3bf2d480becacf4
Drug	Bezafibrate [41859-67-0]; Up 200; 11uM; PC3; HT_HG-U133A	NCOR2 MAP2 ESR1 ZMIZ2 ICAM1 TNK2 HIF3A	4.70e-06	197	77	7	6653_UP
Drug	17-AAG; Down 200; 0.1uM; MCF7; HG-U133A	COL4A2 LZTS1 ESR1 HPS4 ICAM1 TNK2 LTBP1	4.86e-06	198	77	7	221_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	RBM12 SETD1B ZFP36L2 ESR1 MED13L TASOR	3.14e-05	178	77	6	1672_DN
Drug	Ethisterone [434-03-7]; Down 200; 12.8uM; PC3; HT_HG-U133A	COL4A2 ATXN2L NCOR2 ZFP36L2 ZMIZ2 ZYX	4.52e-05	190	77	6	4340_DN
Drug	Methionine sulfoximine (L) [15985-39-4]; Up 200; 22.2uM; MCF7; HT_HG-U133A	NCOR2 GTF2H3 MAST4 ZFP36L2 ESR1 MEX3D	4.80e-05	192	77	6	2831_UP
Drug	PHA-00851261E [724719-49-7]; Down 200; 10uM; PC3; HT_HG-U133A	COL4A2 MAST4 ZFP36L2 RNF216 AHDC1 ZYX	4.80e-05	192	77	6	4330_DN
Drug	Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; PC3; HT_HG-U133A	ATXN2L MAST4 ZFP36L2 ZMIZ2 AHDC1 ZYX	4.94e-05	193	77	6	4338_DN
Drug	Napelline [5008-52-6]; Down 200; 11.2uM; MCF7; HT_HG-U133A	GTF2H3 ZFP36L2 ESR1 ICAM1 AUTS2 TRIM21	5.08e-05	194	77	6	6084_DN
Drug	Proglumide [6620-60-6]; Down 200; 12uM; MCF7; HT_HG-U133A	ATXN2L MYBBP1A MAST4 HPS4 MEX3D BBS4	5.08e-05	194	77	6	3861_DN
Drug	Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A	ZFP36L2 PRRC2C ESR1 ZMIZ2 LTBP1 MED13L	5.08e-05	194	77	6	4361_DN
Drug	diclofenac sodium; Down 200; 10uM; MCF7; HG-U133A	ATXN2L NCOR2 ZFP36L2 ESR1 TNK2 ZYX	5.23e-05	195	77	6	333_DN
Drug	rofecoxib; Up 200; 10uM; MCF7; HG-U133A	ATXN2L NCOR2 SETD1B CAMKV ZFP36L2 ESR1	5.23e-05	195	77	6	166_UP
Drug	alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA	MAP9 ITCH ZFP36L2 ESR1 ICAM1 AHDC1	5.38e-05	196	77	6	990_UP
Drug	Mefexamide hydrochloride [3413-64-7]; Down 200; 12.6uM; PC3; HT_HG-U133A	TRIM66 MAST4 ZFP36L2 ABI2 BBS4 RNF216	5.38e-05	196	77	6	2121_DN
Drug	Hydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A	RBM12 SETD1B HPS4 LTBP1 TTC9 AHDC1	5.53e-05	197	77	6	6011_DN
Drug	Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A	NCOR2 MAP2 ZMIZ2 RNF216 TNK2 TRIM21	5.53e-05	197	77	6	3886_DN
Drug	Bromopride [4093-35-0]; Up 200; 11.6uM; PC3; HT_HG-U133A	NCOR2 MAST4 ZFP36L2 ESR1 CEP41 HIF3A	5.53e-05	197	77	6	3719_UP
Drug	Anabasine [494-52-0]; Up 200; 24.6uM; HL60; HT_HG-U133A	ITCH MAST4 LZTS1 ICAM1 AUTS2 TNK2	5.53e-05	197	77	6	2512_UP
Drug	Oxolinic acid [14698-29-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A	MAST4 SUSD5 ESR1 ZMIZ2 TSKS ZYX	5.53e-05	197	77	6	5519_UP
Drug	Fursultiamine Hydrochloride [2105-43-3]; Up 200; 9.2uM; HL60; HT_HG-U133A	SCARF1 ESR1 ZMIZ2 GPR37L1 LTBP1 TSKS	5.69e-05	198	77	6	2929_UP
Drug	Dipyridamole [58-32-2]; Up 200; 8uM; MCF7; HT_HG-U133A	ATXN2L NCOR2 HOXB3 CAMKV ZFP36L2 ZMIZ2	5.69e-05	198	77	6	5617_UP
Drug	Furazolidone [67-45-8]; Up 200; 17.8uM; MCF7; HT_HG-U133A	SCARF1 NCOR2 MAST4 ESR1 ZMIZ2 HIF3A	5.85e-05	199	77	6	4178_UP
Drug	Nitrofurantoin [67-20-9]; Up 200; 16.8uM; MCF7; HT_HG-U133A	MAST4 ZFP36L2 ESR1 ZMIZ2 CEP41 GPR37L1	5.85e-05	199	77	6	2303_UP
Drug	Telenzepine dihydrochloride [147416-96-4]; Up 200; 9uM; HL60; HT_HG-U133A	ATXN2L ESR1 ZMIZ2 ICAM1 DGKG TTC9	5.85e-05	199	77	6	2388_UP
Drug	Eburnamonine (-) [4880-88-0]; Up 200; 13.6uM; MCF7; HT_HG-U133A	TRIM66 MAST4 CAMKV ZFP36L2 ZMIZ2 ICAM1	5.85e-05	199	77	6	6802_UP
Drug	5-aza-2′-deoxycytidine; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	MAP9 MAST4 ZFP36L2 ZMIZ2 ICAM1 TTC9	5.85e-05	199	77	6	920_DN
Drug	S-(+)-ibuprofen [51146-56-6]; Up 200; 19.4uM; MCF7; HT_HG-U133A	ATXN2L TRIM66 MAP2 ZFP36L2 HPS4 AHDC1	6.02e-05	200	77	6	5311_UP
Drug	Furazolidone [67-45-8]; Up 200; 17.8uM; HL60; HT_HG-U133A	NCOR2 MAP9 ZFP36L2 GPR37L1 TNK2 CDHR5	6.02e-05	200	77	6	3019_UP
Drug	Estramustine	MAP2 ESR1	6.74e-05	4	77	2	DB01196
Drug	C-cluster	ENAM DST NDEL1 MAP2 PRB1	1.10e-04	139	77	5	CID000446537
Drug	DY131	NCOR2 ESR1	1.12e-04	5	77	2	CID000644030
Drug	4,4'-dihydroxybenzophenone	PRB1 ESR1	1.68e-04	6	77	2	CID000069150
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	SETD1B ZFP36L2 ESR1 TTC9 MED13L	2.31e-04	163	77	5	5594_DN
Drug	Ethinyl Estradiol-Norgestrel Combination	ESR1 ICAM1	2.34e-04	7	77	2	ctd:D019304
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	SETD1B MAST4 ZFP36L2 ESR1 MED13L	3.37e-04	177	77	5	6434_DN
Drug	retinoic acid; Up 200; 1uM; MCF7; HT_HG-U133A	NCOR2 ITCH ZFP36L2 HPS4 TTC9	3.46e-04	178	77	5	1636_UP
Drug	Methyl benzethonium chloride [25155-18-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A	COL4A2 ATXN2L CAMKV LZTS1 ZMIZ2	3.55e-04	179	77	5	6045_UP
Drug	Ribavirin [36791-04-5]; Up 200; 16.4uM; HL60; HT_HG-U133A	CAMKV ZFP36L2 ESR1 ICAM1 CEP41	3.83e-04	182	77	5	3142_UP
Drug	Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A	RBM12 MAST4 ESR1 LTBP1 TTC9	3.93e-04	183	77	5	5613_DN
Drug	Helveticoside [630-64-8]; Down 200; 7.4uM; PC3; HT_HG-U133A	ATXN2L ZFP36L2 ESR1 HPS4 ZYX	4.13e-04	185	77	5	4327_DN
Drug	5252917; Up 200; 14uM; MCF7; HT_HG-U133A_EA	MAST4 ICAM1 RNF216 MED13L ZYX	4.13e-04	185	77	5	944_UP
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA	MYBBP1A ZFP36L2 ESR1 ZMIZ2 HPS4	4.23e-04	186	77	5	916_DN
Drug	geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A_EA	TRIM66 ZFP36L2 ESR1 HPS4 ARAP2	4.34e-04	187	77	5	972_DN
Drug	Clotrimazole [23593-75-1]; Up 200; 11.6uM; PC3; HT_HG-U133A	HOXB3 ZFP36L2 ESR1 ZMIZ2 TSKS	4.34e-04	187	77	5	5726_UP
Drug	Lovastatin [75330-75-5]; Up 200; 9.8uM; MCF7; HT_HG-U133A	MAST4 ESR1 MEX3D ICAM1 AUTS2	4.44e-04	188	77	5	2854_UP
Drug	17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A	MAP9 ESR1 ZMIZ2 RNF216 TSKS	4.55e-04	189	77	5	6966_UP
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	MAST4 ZFP36L2 ESR1 ICAM1 AHDC1	4.55e-04	189	77	5	5578_DN
Drug	Harmine hydrochloride [343-27-1]; Down 200; 16uM; PC3; HT_HG-U133A	ITCH RBM12 MAST4 ABI2 ARAP2	4.66e-04	190	77	5	5855_DN
Drug	Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A	GTF2H3 ITCH ZFP36L2 ESR1 RNF216	4.78e-04	191	77	5	4811_DN
Drug	radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	RBM12 MAST4 ZFP36L2 ESR1 TASOR	4.78e-04	191	77	5	1057_DN
Drug	Naproxen [22204-53-1]; Down 200; 17.4uM; MCF7; HT_HG-U133A	MAP9 GTF2H3 MAST4 ZFP36L2 ESR1	4.78e-04	191	77	5	1706_DN
Drug	Cyanocobalamin [68-19-9]; Down 200; 3uM; MCF7; HT_HG-U133A	ZFP36L2 ESR1 ZMIZ2 TRIM21 TTC9	4.89e-04	192	77	5	4395_DN
Drug	Trimethadione [127-48-0]; Up 200; 28uM; MCF7; HT_HG-U133A	GTF2H3 ESR1 MEX3D ICAM1 TTC9	4.89e-04	192	77	5	2846_UP
Drug	LY 294002; Down 200; 10uM; HL60; HT_HG-U133A	COL4A2 ATXN2L NCOR2 ESR1 HPS4	4.89e-04	192	77	5	2699_DN
Drug	Leflunomide [75706-12-6]; Down 200; 14.8uM; MCF7; HT_HG-U133A	ATXN2L MAST4 ZFP36L2 TRIM21 TSKS	4.89e-04	192	77	5	6102_DN
Drug	Noscapine [128-62-1]; Down 200; 9.6uM; MCF7; HT_HG-U133A	MYBBP1A ZFP36L2 ESR1 ICAM1 ZYX	4.89e-04	192	77	5	2745_DN
Drug	PMBs	ENAM ESR1	4.99e-04	10	77	2	CID000065257
Drug	Hycanthone [3105-97-3]; Down 200; 11.2uM; MCF7; HT_HG-U133A	ATXN2L MAST4 ZFP36L2 ESR1 ICAM1	5.01e-04	193	77	5	3229_DN
Drug	PHA-00851261E [724719-49-7]; Up 200; 1uM; MCF7; HT_HG-U133A	COL4A2 NCOR2 SETD1B ESR1 ZMIZ2	5.01e-04	193	77	5	3857_UP
Drug	Nitrofural [59-87-0]; Down 200; 20.2uM; HL60; HT_HG-U133A	ITCH DGKG RNF216 TNK2 LTBP1	5.01e-04	193	77	5	2459_DN
Drug	Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A	ATXN2L MAP2 AUTS2 TTC9 ZYX	5.13e-04	194	77	5	4961_UP
Drug	Phenelzine sulfate [156-51-4]; Up 200; 17uM; MCF7; HT_HG-U133A	MAST4 ZMIZ2 CEP41 GPR37L1 TSKS	5.13e-04	194	77	5	4360_UP
Drug	Albendazole [54965-21-8]; Up 200; 15uM; MCF7; HT_HG-U133A	NCOR2 MAST4 MAP2 ICAM1 ZYX	5.13e-04	194	77	5	7164_UP
Drug	Nadolol [42200-33-9]; Up 200; 13uM; MCF7; HT_HG-U133A	NCOR2 RBM12 ZFP36L2 ZMIZ2 HPS4	5.13e-04	194	77	5	4139_UP
Drug	Nitrofurantoin [67-20-9]; Down 200; 16.8uM; PC3; HT_HG-U133A	ATXN2L NCOR2 ZMIZ2 HPS4 TTC9	5.13e-04	194	77	5	3674_DN
Drug	Methylergometrine maleate [113-42-8]; Up 200; 8.8uM; MCF7; HT_HG-U133A	SETD1B ZFP36L2 TRIM21 TTC9 ZYX	5.13e-04	194	77	5	5303_UP
Drug	Sulfaguanidine [57-67-0]; Down 200; 18.6uM; MCF7; HT_HG-U133A	ZFP36L2 ESR1 RNF216 TTC9 ANKLE2	5.13e-04	194	77	5	4839_DN
Drug	Etifenin [63245-28-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A	NCOR2 ESR1 ZMIZ2 MEX3D TNK2	5.13e-04	194	77	5	2838_UP
Drug	clofibrate; Up 200; 150uM; MCF7; HG-U133A	ATXN2L LZTS1 ESR1 ICAM1 TNK2	5.13e-04	194	77	5	263_UP
Drug	radicicol; Down 200; 0.1uM; MCF7; HG-U133A	ATXN2L ZFP36L2 ESR1 ICAM1 CEP41	5.25e-04	195	77	5	489_DN
Drug	3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Up 200; 13.8uM; PC3; HT_HG-U133A	MAST4 CAMKV ESR1 HIF3A TSKS	5.25e-04	195	77	5	4298_UP
Drug	Cephalothin sodium salt [58-71-9]; Up 200; 9.6uM; HL60; HT_HG-U133A	HOXB3 LZTS1 ESR1 CDHR5 TSKS	5.25e-04	195	77	5	2517_UP
Drug	Cimetidine [51481-61-9]; Up 200; 15.8uM; PC3; HG-U133A	NCOR2 CAMKV ZFP36L2 ESR1 ZMIZ2	5.25e-04	195	77	5	1884_UP
Drug	wortmannin from Penicillium funiculosum; Up 200; 0.01uM; HL60; HT_HG-U133A	MYBBP1A SETD1B ZFP36L2 ICAM1 AHDC1	5.25e-04	195	77	5	1184_UP
Drug	Aconitine [302-27-2]; Down 200; 6.2uM; MCF7; HT_HG-U133A	ABI2 ESR1 LTBP1 TTC9 ZYX	5.25e-04	195	77	5	2776_DN
Drug	PHA-00851261E [724719-49-7]; Down 200; 1uM; PC3; HT_HG-U133A	COL4A2 ZMIZ2 ICAM1 RNF216 AHDC1	5.25e-04	195	77	5	4333_DN
Drug	Cisapride [81098-60-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A	TRIM66 MAST4 ZFP36L2 HPS4 TRIM21	5.25e-04	195	77	5	5305_UP
Drug	Rapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A	MAP9 ZFP36L2 GPR37L1 DGKG TNK2	5.25e-04	195	77	5	2702_UP
Drug	Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A	RASIP1 ESR1 ICAM1 AUTS2 AHDC1	5.25e-04	195	77	5	4180_DN
Drug	3-Acetamidocoumarin [779-30-6]; Up 200; 19.6uM; MCF7; HT_HG-U133A	ATXN2L ESR1 ZMIZ2 HPS4 TNK2	5.25e-04	195	77	5	7361_UP
Drug	Sotalol hydrochloride [959-24-0]; Up 200; 13uM; MCF7; HT_HG-U133A	ATXN2L ESR1 ZMIZ2 HPS4 TTC9	5.37e-04	196	77	5	7338_UP
Drug	Tetracycline hydrochloride [64-75-5]; Up 200; 8.4uM; PC3; HT_HG-U133A	ATXN2L NCOR2 ZFP36L2 ESR1 TSKS	5.37e-04	196	77	5	5757_UP
Drug	Triamterene [396-01-0]; Up 200; 15.8uM; MCF7; HT_HG-U133A	ATXN2L TRIM66 ZFP36L2 RNF216 TSKS	5.37e-04	196	77	5	1697_UP
Drug	Apomorphine hydrochloride hemihydrate [41372-20-7]; Down 200; 6.4uM; HL60; HG-U133A	MPP1 ITCH ABI2 RNF216 TASOR	5.37e-04	196	77	5	2005_DN
Drug	Pempidine tartrate [546-48-5]; Up 200; 13uM; MCF7; HT_HG-U133A	COL4A2 HOXB3 PDE6A CAMKV HIF3A	5.37e-04	196	77	5	6027_UP
Drug	Estrone [53-16-7]; Up 200; 14.8uM; PC3; HT_HG-U133A	RASIP1 GTF2H3 ESR1 ICAM1 HIF3A	5.37e-04	196	77	5	6647_UP
Drug	2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A	RBM12 ZFP36L2 ESR1 HPS4 LTBP1	5.37e-04	196	77	5	1639_UP
Drug	Tracazolate hydrochloride [41094-88-6]; Down 200; 11.8uM; PC3; HT_HG-U133A	ZFP36L2 ESR1 ZMIZ2 TRIM21 AHDC1	5.37e-04	196	77	5	6619_DN
Drug	Mesalamine [89-57-6]; Up 200; 26.2uM; PC3; HT_HG-U133A	HOXB3 ZFP36L2 ESR1 TNK2 TTC9	5.37e-04	196	77	5	5888_UP
Drug	Benzamil hydrochloride [2898-76-2]; Up 200; 11.2uM; PC3; HT_HG-U133A	NCOR2 MAST4 ESR1 ZMIZ2 CEP41	5.37e-04	196	77	5	3738_UP
Drug	LY 294002; Down 200; 10uM; HL60; HT_HG-U133A	COL4A2 ATXN2L NCOR2 ITCH ESR1	5.37e-04	196	77	5	2687_DN
Drug	Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; MCF7; HT_HG-U133A	ATXN2L ESR1 ZMIZ2 HPS4 ANKLE2	5.37e-04	196	77	5	2314_DN
Drug	Methoxy-8-psoralen [298-81-7]; Down 200; 18.6uM; MCF7; HT_HG-U133A	TRIM66 RBM12 ZMIZ2 HPS4 ZYX	5.37e-04	196	77	5	5007_DN
Drug	Mifepristone [84371-65-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A	MAP9 MYBBP1A ZFP36L2 ESR1 TASOR	5.37e-04	196	77	5	7183_DN
Drug	Etofenamate [30544-47-9]; Down 200; 10.8uM; MCF7; HT_HG-U133A	PRRC2C ESR1 ICAM1 LTBP1 TTC9	5.37e-04	196	77	5	4108_DN
Drug	Alcuronium chloride [15180-03-7]; Down 200; 5.4uM; MCF7; HT_HG-U133A	MAST4 ZMIZ2 RNF216 TRIM21 ZYX	5.37e-04	196	77	5	4409_DN
Drug	benzophenone	DST LZTS1 ESR1	5.42e-04	47	77	3	CID000003102
Drug	Cortisone [53-06-5]; Up 200; 11uM; MCF7; HT_HG-U133A	ZMIZ2 ICAM1 TRIM21 LTBP1 TTC9	5.50e-04	197	77	5	7458_UP
Drug	Amiprilose hydrochloride [60414-06-4]; Up 200; 11.8uM; HL60; HT_HG-U133A	NCOR2 MAP9 HOXB3 SETD1B SUSD5	5.50e-04	197	77	5	3000_UP
Drug	Cytisine (-) [485-35-8]; Down 200; 21uM; MCF7; HT_HG-U133A	RBM12 SETD1B ZFP36L2 RNF216 TNK2	5.50e-04	197	77	5	6217_DN
Disease	Delayed speech and language development	OXR1 MED13	6.69e-05	5	77	2	C0454644
Disease	motion sickness	HOXB3 AUTS2 ARAP2	2.72e-04	48	77	3	EFO_0006928
Disease	body surface area	TRIM66 NCOR2 ESR1 AUTS2 DGKG LTBP1 MED13L TASOR	2.73e-04	643	77	8	EFO_0022196
Disease	vital capacity	ATXN2L TRIM66 NCOR2 DST MAP2 LZTS1 SUSD5 ESR1 CEP83 AUTS2 LTBP1	3.52e-04	1236	77	11	EFO_0004312
Disease	body mass index, osteoarthritis	CAMKV LTBP1 DCAF12	3.85e-04	54	77	3	EFO_0004340, MONDO_0005178
Disease	body weight	ATXN2L TRIM66 MAST4 ASXL3 ESR1 ZMIZ2 AUTS2 DGKG CHD8 LTBP1 HIF3A	4.17e-04	1261	77	11	EFO_0004338
Disease	monocyte count	COL4A2 NCOR2 ZMIZ2 ICAM1 RNF216 MED13L RPA2 AHDC1 VARS1 ZYX DCAF12	6.11e-04	1320	77	11	EFO_0005091
Disease	cyclic adenosine monophosphate measurement	MAST4 ARAP2	8.91e-04	17	77	2	EFO_0010473
Disease	hippocampal volume	DACT1 MAST4 MAP2 MED13L ARAP2	1.09e-03	297	77	5	EFO_0005035
Disease	hippocampal tail volume	DACT1 MAST4	1.12e-03	19	77	2	EFO_0009398
Disease	total blood protein measurement	COL4A2 NCOR2 SUSD5 ESR1 MAML2 DCAF12	1.14e-03	449	77	6	EFO_0004536
Disease	seborrheic dermatitis	MAST4 C1orf94	1.24e-03	20	77	2	EFO_1000764
Disease	BRCAX breast cancer	ESR1 DCAF12	1.24e-03	20	77	2	EFO_0009443
Disease	urinary albumin to creatinine ratio	RASIP1 ABI2 PRRC2C AUTS2	1.26e-03	179	77	4	EFO_0007778
Disease	osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty	NCOR2 MAML2	1.37e-03	21	77	2	EFO_0004616, EFO_0010726, EFO_1000786
Disease	alcohol consumption measurement	ATXN2L TRIM66 RASIP1 DACT1 NCOR2 MAST4 ABI2 AUTS2 WDR90 ARAP2	1.42e-03	1242	77	10	EFO_0007878
Disease	physical activity	SETD1B ESR1 ARAP2	1.60e-03	88	77	3	EFO_0003940
Disease	peripheral arterial disease, traffic air pollution measurement	OXR1 LZTS1 ESR1 C1orf94	1.69e-03	194	77	4	EFO_0004265, EFO_0007908
Disease	breast carcinoma (is_implicated_in)	LZTS1 ESR1	1.94e-03	25	77	2	DOID:3459 (is_implicated_in)
Disease	alcohol use disorder measurement, alcohol consumption measurement	TRIM66 RASIP1 AUTS2	2.11e-03	97	77	3	EFO_0007878, EFO_0009458
Disease	retinal vasculature measurement	COL4A2 RASIP1 MAP2 LZTS1 PERM1 MED13L	2.33e-03	517	77	6	EFO_0010554
Disease	osteoarthritis (is_implicated_in)	NCOR2 ESR1	2.43e-03	28	77	2	DOID:8398 (is_implicated_in)
Disease	obesity (implicated_via_orthology)	ESR1 BBS4 MED13L MED13	2.45e-03	215	77	4	DOID:9970 (implicated_via_orthology)
Disease	cortical surface area measurement	ATXN2L DACT1 ITCH NDEL1 MAST4 MAP2 PRRC2C AUTS2 PERM1 MED13L	2.55e-03	1345	77	10	EFO_0010736

Protein segments in the cluster

Peptide	Gene	Start	Entry
LPSGAGGTSQFTKPP	BBS4	481	Q96RK4
SVAGSNPAKPGLGSP	ANKLE2	901	Q86XL3
QPVKGSAPAGNPGAT	CHD8	251	Q9HCK8
ETFLGAQKPGPQPGA	DISP3	26	Q9P2K9
SEPAKPTNGGQPYAS	CCDC116	351	Q8IYX3
SGLAPGQPFPSSQGS	ANKRD10	311	Q9NXR5
GKGNPGEQSPSPEQF	CEP41	111	Q9BYV8
TPPSNISGAPGDKGA	COL4A2	1271	P08572
PSEAGGANGNISKPP	ABCA13	4376	Q86UQ4
NGTNGLLEGSPPSPF	ARAP2	231	Q8WZ64
TFPNNFPPGGDSGLT	CEP83	11	Q9Y592
KNGTLFPEQVPSGPG	AHDC1	746	Q5TGY3
QDNLFSGPGPKEPTG	C1orf94	271	Q6P1W5
GGDTAQTPKPGTSQP	CDHR5	536	Q9HBB8
RADNSGKPQQPPGGF	ASXL3	1446	Q9C0F0
GQSTGKGPPQSPVFE	ATXN2L	101	Q8WWM7
PQGGGKPPSSAQTAE	TNK2	691	Q07912
GGAPNLADGFTSPTP	ABI2	321	Q9NYB9
GSKEANNGPPFNFPG	RBM12	711	Q9NTZ6
SNPFTAGAELPGPGA	RASIP1	721	Q5U651
KFGTGPQSSGQPRVP	DZIP1L	751	Q8IYY4
DTGQNGPKPPATLGA	NCOR2	761	Q9Y618
NGSAAPPAGSAFNPT	MED13L	1551	Q71F56
GGQAGVDFDPSTPPK	LZTS1	91	Q9Y250
AGSPGPLKSPQGASA	MAGEA5P	56	P43359
FSPGSEGNASGKDPN	MAP9	256	Q49MG5
TPGFPSGLVPNFSSG	DST	556	Q03001
GFPNPQDGAFSLSGK	HPS4	681	Q9NQG7
SNGLGGFPPLNSVSP	ESR1	91	P03372
NPGGHPAAAPFTKQG	LTBP1	121	Q14766
QPGGNPSPGGATTSK	PDE6A	841	P16499
PTGPFGSLQGAFQPK	AUTS2	596	Q8WXX7
PQGPVSFPGGAAFST	MEX3D	546	Q86XN8
VNGAPGSPTEPAGQK	MYBBP1A	1261	Q9BQG0
GTPDANSLAPPGKAG	PYGO2	301	Q9BRQ0
SSAGPSPGPFGQEKI	MAML2	466	Q8IZL2
APGFNPLAGAGKQTP	OXR1	21	Q8N573
SGNNSPSLSNGGFKP	ITCH	236	Q96J02
PKQVFNLDNGGPTPG	DGKG	461	P49619
GGSAPAKFQPASAPA	CKAP5	1096	Q14008
PSGGIPSLNNGTFSP	DACT1	401	Q9NYF0
APEGATGQAPPSSKG	CAMKV	471	Q8NCB2
KAPASPGAGSDAQGP	DCAF12	11	Q5T6F0
SPNPGKDGGTPDSGQ	GPR37L1	86	O60883
SNSSNGGGPSKSGPP	HOXB3	101	P14651
GPDVFPATPGSQNKA	MAST4	2246	O15021
FPGPGNAQTSVSPSK	ICAM1	21	P05362
PNPKGSQGGNDTSPT	ENAM	256	Q9NRM1
GSPAPGSPAQVKGQE	MPP1	51	Q00013
FSVAGPSPNKPGSGQ	PERM1	506	Q5SV97
KGFVPSPTSQPGGHE	VARS1	966	P26640
GNTDGPSGPFVGKND	SUSD5	341	O60279
SGNSFPPQQAGSPLK	SUPT20HL1	476	Q3ZLR7
SSFKPVQAPGSGAPA	SUPT20HL1	561	Q3ZLR7
DTTQPGGPFQPRAGS	HIF3A	651	Q9Y2N7
GNNGPPKSGRNFSGP	PRRC2C	1556	Q9Y520
GGSSGPPFKAQPQDS	SETD1B	361	Q9UPS6
GPPGISEFTKPSGQT	RNF216	81	Q9NWF9
SPFGAADQDPFPKSG	MED13	1201	Q9UHV7
GQSPNSAPKAGLPGA	SCARF1	751	Q14162
SGNSFPPQQAGSPLK	SUPT20HL2	476	P0C7V6
GGNLPPVSPNDSGAK	TASOR	1096	Q9UK61
SGGSVGNKGSPQPPH	SHC4	46	Q6S5L8
PQGPPAQGGSKSQSA	PRB1	321	P04280
GPHPQKQTFSSGPGI	WDR90	606	Q96KV7
SPNSRGTGEPGPKFH	TVP23C	256	Q96ET8
TQSPGGFGSPAPSQA	RPA2	21	P15927
HQKPPSFPSTDSGGG	PLEKHG4B	631	Q96PX9
GSSAGTPPKQGGSAP	TSKS	576	Q9UJT2
QGASQPNPPGFGSIS	NUP153	1331	P49790
FSPGFNDGGKNTAPL	TRIM21	446	P19474
GKQFDSPMPSPFQGG	MAP2	306	P11137
NFSSGTIPGTPGPNG	ZMIZ2	571	Q8NF64
SPGAPGGSGSQPNQK	ZYX	281	Q15942
GPFFPRAQKGSPGVN	TRIM66	41	O15016
PGSCSPKFPGAANGS	ZFP36L2	71	P47974
GNPPEFNPSGSKDGK	GTF2H3	86	Q13889
SAAGAKGNPSPPAAG	TTC9	6	Q92623
QQPHPGFTGGLSKPA	TRERF1	206	Q96PN7
RAQPGSPESSGQPKG	TRERF1	486	Q96PN7
SPESSGQPKGAFGEQ	TRERF1	491	Q96PN7
ENTFPSPKAIPNGFG	NDEL1	226	Q9GZM8